Targeting Hsp90 in urothelial carcinoma

Urothelial carcinoma, or transitional cell carcinoma, is the most common urologic malignancy that carries significant morbidity, mortality, recurrence risk and associated health care costs. Despite use of current chemotherapies and immunotherapies, long-term remission in patients with muscle-invasiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehab, Mahmoud, Caza, Tiffany, Skotnicki, Kamil, Landas, Steve, Bratslavsky, Gennady, Mollapour, Mehdi, Bourboulia, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496161/
https://www.ncbi.nlm.nih.gov/pubmed/25909217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496161/
https://www.ncbi.nlm.nih.gov/pubmed/25909217

Ejemplares similares